Print version of this report
Type of Product Medical Device
TGA Recall Reference RC-2016-RN-01142-1
Product Name/Description Sensitest Agar

Product Code: 04134

All lot numbers affected

ARTG Number: 201986
Recall Action Level Hospital
Recall Action Classification Class II
Recall Action Commencement Date 2/09/2016
Responsible Entity Biomerieux Australia Pty Ltd
Reason/Issue BioMérieux have received reports regarding an issue with the use of BioMérieux 04134 Sensitest Agar. The issue is related to the testing of Cefoxitin 10µg disc on Staphylococcus aureus yielding zones of inhibition of 5.5 to 6.5 annular radius with isolates of Methicillin-resistant Staphylococcus aureus (MRSA) (confirmed MecA positive). In addition, there are also problems with the lawn growth of Staphylococcus intermedius which impacts adversely on susceptibility testing of that organism. The size (<8mm) and morphology of the zone should immediately raise suspicion however, the isolates could be reported as susceptible to Cefoxitin (methicillin). Therefore, there is the potential for underdiagnoses of MRSA.
Recall Action Recall for Product Correction
Recall Action Instructions As a precautionary measure, BioMérieux is strongly recommending that, as an interim measure while investigations are continuing, to cease using 04134 Sensitest Agar for Staphylococcus sp. and test staphylococci on 04091 Mueller Hinton Agar. It is also recommended that recent results be re-examined using 04091 Mueller Hinton Agar and/or perform MecA testing. Discuss any concerns regarding previously reported results with the Laboratory Medical Director to determine the appropriate course of action.

BioMérieux is continuing to investigate the issue in consultation with the Therapeutic Goods Administration (TGA). Further correspondence may be provided following the outcome of the investigations.
This action has been closed-out on 22/03/2018.
Contact Information 1800 333 421 - BioMérieux Helpdesk